Monkey Pox
12
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Neutralizing Power of Serum Antibodies - 2
Observational Mondkeypox Pregnancy Cohort
Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
Clinical and Biological Aspects of the MONKEYPOX Disease
Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak
Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS
Mpox Paediatric and Adolescent Clinical Study
Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users
FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues
Phase I Trial of an Investigational Small Pox Medication